{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-022944","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.576162+00:00","generated_at":"2026-06-15T19:12:01.942571+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"SIGA Q1 revenues $8.3M, net loss $0.9M; declares $0.45 special dividend","bullets":["Q1 2023 revenues $8.3M vs $10.5M in Q1 2022; net loss $0.9M ($0.01 diluted loss per share).","Operating loss $2.1M, compared to $1.4M in prior-year quarter.","Special dividend of $0.45 per share declared, payable June 1, 2023 to holders of record May 16, 2023.","Repurchased 1.1M shares for $7.5M in Q1 2023.","CEO targeting ~$11M oral TPOXX deliveries to DoD and ~$113M to SNS in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-022944","json":"https://secwatch.observer/filing/0001140361-23-022944.json","markdown":"https://secwatch.observer/filing/0001140361-23-022944.md","text":"https://secwatch.observer/filing/0001140361-23-022944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036123022944/0001140361-23-022944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036123022944/brhc20052438_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T19:12:01.942571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f8ef75fc26e0026a364b05a9cf53192a54ccf464","claim":"SIGA TECHNOLOGIES INC reported three months ended March 31, 2023 results: revenue $8.3, net income $(0.9), EPS ($0.01) per share.","evidence_excerpt":"Summary Financial Results ($ in millions, except per share amounts) Three Months Ended March 31, 2023 in comparison to Three Months Ended March 31, 2022 Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Total Revenues $8.3 $10.5 Operating Loss (1) $(2.1) $(1.4) Loss before Income Taxes (1) $(1.2) $(1.1) Net Loss $(0.9) $(0.4) Diluted Loss per Share ($0.01) per share ($0.01) per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036123022944/0001140361-23-022944-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Revenue","value":"$8.3"},{"label":"Net income","value":"$(0.9)"},{"label":"EPS","value":"($0.01) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}